CN104383247A - Traditional Chinese medicine for treating phthisis - Google Patents
Traditional Chinese medicine for treating phthisis Download PDFInfo
- Publication number
- CN104383247A CN104383247A CN201410674845.9A CN201410674845A CN104383247A CN 104383247 A CN104383247 A CN 104383247A CN 201410674845 A CN201410674845 A CN 201410674845A CN 104383247 A CN104383247 A CN 104383247A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- radix
- parts
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating phthisis, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine is used for thoroughly removing pathogens in the lung and the respiratory tract as a main function, and clearing away heat and removing blood stasis, and smoothing the lung and tonifying the spleen as auxiliary functions by adopting the traditional Chinese medicine theory. The formula of the traditional Chinese medicine comprises liquorice, cassia twig, red ginseng, radix rehmanniae recen, radix ophiopogonis, donkey-hide gelatin, edestan and spina date seed. The traditional Chinese medicine is simple in preparation process, wide in raw material source, and free of an obvious toxic or side effect, and has a significant curative effect on phthisis.
Description
Technical field
The present invention relates to one and treat phthisical Chinese medicine, is specifically Chinese medicine prepared by raw material with Chinese herbal medicine.
Background technology
Pulmonary tuberculosis disease belongs to the extremely strong pulmonary disease of infectiousness, proves according to relevant data and experimentation, and phthisical main pathogenic is: the primary pulmonary tuberculosis of Childhood is delayed, the daily life source of infection infects, nosocomial infection.Its main harm is that infectiousness is stronger, the infection rate of tuberculosis is high, its main infective agent infects, tubercule bacillus is propagated widely in crowd, a large amount of healthy population is carried disease germs infection, Tuberculous disease is once thoroughly or in body also there is not tubercule bacillus in treatment, or not cutting off the source of infection will cause subinfection repeatedly to be fallen ill again, carry disease germs and propagate tubercule bacillus.Phthisical onset general comparatively anxious, delay is difficult, often show as the symptom of respiratory tract infection, seriously can cause dyspnea, pulmonary's major injury causes adverse consequences, some patients is not thoroughly treated, cause the course of disease to extend, prolongedly not heal, canceration can be caused in the long-term course of disease to worsen and occur.
The people of 1/3 is had to infect tulase in the world, the whole world has 3,000,000 people to die from pulmonary tuberculosis every year, China's pulmonary tuberculosis rate reaches 3,67/,100,000, poverty is caused because of hectic, or not within minority because of poor and hectic, that Here it is is so-called " because poorly causing a disease, driving into poverty by medical crises ", if tuberculosis epidemic situation is not controlled, also will cause significant impact to national economy.Because most of lunger is between twenty and fifty, be in the age bracket of most production capacity, only this just makes the annual direct losses of gross national product more than 9,000,000,000 yuan according to estimates.
Pulmonary tuberculosis is called as " pulmonary tuberculosis " in the traditional Chinese medical science, analyze like this in modern " Chinese Internal Medicine " to phthisical pathogenesis: pulmonary tuberculosis invades human lung by tubercule bacillus and causes, both the pathological change after disease, one is lung yin coup injury, impairment of purifying function of the lung, therefore cough, lose heart, lung network wound is then spat blood, blood stasis or diseases caused by retention of fluid resistance network then chest pain, lung yin is both empty, namely interior-heat rises, therefore hectic fever endlessly, lung associating with skin and hair, the deficiency of the lung then fur is not solid, interior-heat is rising, then see night sweat, pneumonopathy with the passing of time, spleen kidney is held concurrently tired by it, insufficiency of the spleen then lack of appetite, become thin, deficiency of kidney yin, then interior-heat benefit is contained, heat is more contained, cloudy essence is more lost, gas is also thereupon not enough, then the card of asthenia universalis is caused.
Current pulmonary tuberculosis controls mainly through preventing and treating, and treat pulmonary tuberculosis medicine used 80% and be: isoniazid, rifampicin, ethambutol, pyrazinamide, streptomycin five kinds, but be easy to produce drug resistance, do not reach the effect of healing, cause the dual-pressure on spirit and health to the family of patient.
Summary of the invention
The present invention treats the root that phthisical advantage is from disease, and thoroughly remove the pathogen of pulmonary and respiratory tract, rapid-action, without obvious toxic and side effects, raw material sources are extensive.
For achieving the above object, one treats phthisical Chinese medicine, it is characterized in that the weight portion of raw material is: Radix Glycyrrhizae 220-260 part, Ramulus Cinnamomi 100-120 part, Radix Ginseng Rubra 160-180 part, Radix Rehmanniae 130-150 part, Radix Ophiopogonis 80-100 part, Colla Corii Asini 100-120 part, Fructus Cannabis 60-80 part, Semen Ziziphi Spinosae 120-140 part.
In medicine of the present invention, Radix Glycyrrhizae: for insufficiency of heart-QI, severe palpitation, irregularly intermittent and regularly intermittent pulse, and deficiency of spleen-QI and stomach-QI, fatigue and weakness; Ramulus Cinnamomi: pungent, sweet, temperature, the drugs for dispelling internal cold that interior cold is conventional, there is effect of complement sun, promoting blood circulation, warming the spleen and stomach, normal and invigorating the liver and kidney medicine, fill blood medicine compatibility, treatment insufficiency of kidney-YANG, decline of the fire from the gate of life, cold extremities faint pulse, treat coldness and pain in the epigastrium, arthralgia due to cold lumbago with other drugs for dispelling internal cold compatibility, has the effect of significantly analgesia and anti-cancer and cancer-preventing; Radix Ginseng Rubra: sweet, be slightly cold, nontoxic, deficiency of spleen-QI and stomach-QI, anorexia, yang deficiency pant, spontaneous sweating, dizziness of breathing hard, dyspnea with rapid respiration wild, chronic cough of deficiency lung; Radix Rehmanniae: sweet, bitter, cold, controls fever due to yin deficiency, quenches one's thirst, and spits blood, epistaxis, metrorrhagia, menoxenia, frequent fetal movement, and the moon hinders constipation; Radix Ophiopogonis: sweet, micro-hardship, is slightly cold, YIN nourishing and the production of body fluid promoting, and lung moistening clears away heart-fire, and for dryness of the lung dry cough, deficiency of YIN consumptive disease is coughed, sore throat pharyngalgia, and Tianjin wound is thirsty, and interior-heat is quenched one's thirst, vexed insomnia, dryness of the intestine constipation; Colla Corii Asini: YIN nourishing of enriching blood, moisturizes, hemostasis, for blood deficiency and yellow complexion, and dizzy cardiopalmus, dysphoria and insomnia, xeropulmonary cough; Fructus Cannabis: sweet in the mouth, property is put down, nontoxic, invigorating the spleen and replenishing QI, controls apoplexy and perspires, harness the river swollen, diuresis, removing mass blood, dredging blood vessel; Semen Ziziphi Spinosae: sweet, flat, mind tranquilizing and the heart calming, nourishing the liver, arresting sweating, restlessness of asrhenia type and insomnia, palpitation with fear palpitation with a distress feeling, body empty spontaneous perspiration, night sweat.
Detailed description of the invention
Embodiment 1
One treats phthisical Chinese medicine, it is characterized in that the weight portion of raw material is: Radix Glycyrrhizae 220-260 part, Ramulus Cinnamomi 100-120 part, Radix Ginseng Rubra 160-180 part, Radix Rehmanniae 130-150 part, Radix Ophiopogonis 80-100 part, Colla Corii Asini 100-120 part, Fructus Cannabis 60-80 part, Semen Ziziphi Spinosae 120-140 part.
Embodiment 2
One treats phthisical Chinese medicine, and its preferred weight part is: 250 parts, Radix Glycyrrhizae, Ramulus Cinnamomi 100 parts, Radix Ginseng Rubra 180 parts, Radix Rehmanniae 140 parts, Radix Ophiopogonis 85 parts, 110 parts, Colla Corii Asini, Fructus Cannabis 75 parts, Semen Ziziphi Spinosae 120 parts.
By the Radix Glycyrrhizae alcohol solution dipping of 30%, filter, crystallization, porphyrize after dry; Ramulus Cinnamomi, Radix Ophiopogonis, Radix Rehmanniae, Colla Corii Asini, Fructus Cannabis are ground into fine powder, sieve, mixing; Radix Ginseng Rubra is secondary with the soak with ethanol filter 23 of 60%, and the solid after filtrate concentrate drying carries out porphyrize; Smashed to pieces by Semen Ziziphi Spinosae, heat with high heat, take out when being calcined to crisp, crushed after being dried becomes fine powder, sieves, and is then fully mixed by the medicine of all process, and mixing, makes granule, finally add adjuvant and make capsule.Specification: every heavy 0.3g.Usage and consumption: oral, one time 2, every day 3 times.
1. clinical data
1.1 physical data: this is organized 42 examples and clarifies a diagnosis as phthisical patient, wherein male patient 26 example, female patient 16 example, age 16-52 year.
1.2 symptom features: the reduction of patient's immunity of organisms, cough, expectoration, night sweat, low grade fever, with dizziness headache, dyspnea.
2. take mode: oral, one time 2, every day 3 times.
3. therapeutic outcome
3.1 efficacy assessment standards are recovered: ill symptoms disappears, and drug withdrawal was not recurred after 1 year.Take a turn for the better: ill symptoms disappears, and drug withdrawal was recurred after 1 year, or the rear ill symptoms for the treatment of obviously alleviates, recurrent number reduces.Invalid: after treatment, ill symptoms is without being clearly better or using other method persons instead.
3.2 therapeutic effect 20 days are a course for the treatment of, the general 2-4 of the lighter the recovery from illness course for the treatment of, the general 6-8 of severe one the recovery from illness course for the treatment of.By 31 examples of fully recovering after above-mentioned standard care, account for 73.8%; Take a turn for the better 8 examples, accounts for 19.1%; Invalid 3 examples, account for 7.1%, total effective rate is 92.9%.
4. toxic and side effects does not find obvious side effect in clinical studies.
The technology those of ordinary skill of this area all can be understood, and it is all possible in protection scope of the present invention, modifying for above-described embodiment, adding and replacing, and it does not all exceed protection scope of the present invention.
Claims (2)
1. treat a phthisical Chinese medicine, it is characterized in that the weight portion of raw material is: Radix Glycyrrhizae 220-260 part, Ramulus Cinnamomi 100-120 part, Radix Ginseng Rubra 160-180 part, Radix Rehmanniae 130-150 part, Radix Ophiopogonis 80-100 part, Colla Corii Asini 100-120 part, Fructus Cannabis 60-80 part, Semen Ziziphi Spinosae 120-140 part.
2. the phthisical Chinese medicine for the treatment of according to claim 1, its optimum formula is: 250 parts, Radix Glycyrrhizae, Ramulus Cinnamomi 100 parts, Radix Ginseng Rubra 180 parts, Radix Rehmanniae 140 parts, Radix Ophiopogonis 85 parts, 110 parts, Colla Corii Asini, Fructus Cannabis 75 parts, Semen Ziziphi Spinosae 120 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410674845.9A CN104383247A (en) | 2014-11-24 | 2014-11-24 | Traditional Chinese medicine for treating phthisis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410674845.9A CN104383247A (en) | 2014-11-24 | 2014-11-24 | Traditional Chinese medicine for treating phthisis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104383247A true CN104383247A (en) | 2015-03-04 |
Family
ID=52601271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410674845.9A Pending CN104383247A (en) | 2014-11-24 | 2014-11-24 | Traditional Chinese medicine for treating phthisis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104383247A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031454A (en) * | 2015-09-10 | 2015-11-11 | 耿云花 | Medicine for treating pulmonary tuberculosis |
-
2014
- 2014-11-24 CN CN201410674845.9A patent/CN104383247A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031454A (en) * | 2015-09-10 | 2015-11-11 | 耿云花 | Medicine for treating pulmonary tuberculosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102283999B (en) | Traditional Chinese medicine preparation for treating insomnia | |
CN104998098A (en) | Solid beverage capable of improving sleep and preparation method thereof | |
CN103550435B (en) | Traditional Chinese medicine for treating tristimania | |
CN102772780A (en) | Medicament for treating ahypnosis and preparation method thereof | |
CN104338050A (en) | Health care product capable of improving sleep quality | |
CN102178892B (en) | Chinese medicinal composition for treating depression | |
CN103877512A (en) | Traditional Chinese medicine for treating arrhythmia and preparation method thereof | |
CN103550384B (en) | Traditional Chinese medicine composition for treating liver-blood deficiency type night sweat | |
CN105106440A (en) | Traditional Chinese medicine composition for treating headache and dizziness induced by lumbar anesthesia | |
CN104800553B (en) | A kind of Chinese medicine composition for treating climacteric insomnia disease and preparation method thereof | |
CN104623583A (en) | Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid | |
CN104383247A (en) | Traditional Chinese medicine for treating phthisis | |
CN105232999A (en) | Traditional Chinese medicine composition for tonifying qi, activating blood and controlling nocturnal emission | |
CN104324188A (en) | Traditional Chinese medicine composition for treating childhood tourette syndrome and preparation method thereof | |
CN104491760A (en) | Traditional Chinese medicine composition for treating depression | |
CN104474045A (en) | Traditional Chinese medicine patch for treating febrile convulsion of infants and preparation method of traditional Chinese medicine patch | |
CN107898990A (en) | A kind of Chinese medicine preparation for treating neurosis and preparation method thereof | |
CN103705780A (en) | Medicament for treating intractable insomnia | |
CN103349709B (en) | Traditional Chinese medicine preparation capable of tonifying qi and yin and nourishing liver and kidney | |
CN105381064A (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
CN105214001B (en) | A kind of Chinese medicine composition for treating hypertensive patients coronary heart disease | |
CN104162038A (en) | Traditional Chinese medicine composition for treating neonatal seizures and preparation method thereof | |
CN104383284A (en) | Traditional Chinese medicine for treating blood stasis block syndrome type somnolence disease | |
CN104258125A (en) | Traditional Chinese medicine pills for treating postpartum anemia | |
CN102626504A (en) | Chinese medicinal oral liquid for preventing and treating depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150304 |